Our Pricing

What Is Mounjaro and How Can Residents of Stockton-on-Tees Access It?

Published: 1 October 2026

If you're searching for Mounjaro Stockton-on-Tees, you're looking for a UK-licensed source of tirzepatide weight loss injections with convenient home delivery to your area. Mounjaro is a once-weekly GLP-1 receptor agonist approved by the MHRA for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities[1]. Cured Pharmacy offers Mounjaro from £124.99 per box with free clinical assessment, discreet packaging, and next-day delivery across Stockton-on-Tees and the wider Tees Valley.

How Does Mounjaro Work for Weight Loss in Stockton-on-Tees Patients?

Mounjaro Stockton-on-Tees prescriptions are based on the active ingredient tirzepatide, a dual GIP/GLP-1 receptor agonist that targets two key incretin pathways involved in appetite regulation and glucose metabolism[1]. Unlike single-agonist therapies, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, leading to enhanced satiety, reduced caloric intake, and improved glycaemic control.

In the SURPASS-1 clinical trial, participants receiving tirzepatide 15mg achieved an average weight reduction of 9.5kg over 40 weeks compared to placebo[2]. The dual-agonist mechanism slows gastric emptying, increases insulin secretion in response to meals, and suppresses glucagon release, all of which contribute to sustained weight loss when combined with a reduced-calorie diet and increased physical activity[1]. For residents of Stockton-on-Tees seeking evidence-based weight management, Mounjaro offers a clinically proven option with robust trial data.

Eligibility Criteria for Mounjaro Stockton-on-Tees Online Prescriptions

To receive a Mounjaro Stockton-on-Tees prescription through Cured Pharmacy, you must meet MHRA-approved clinical criteria. Mounjaro is licensed for adults aged 18 and over with a body mass index (BMI) of 30 kg/m² or higher, or 27 kg/m² or higher if you have at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea[1].

Our UK-registered prescribers conduct a comprehensive online assessment covering your medical history, current medications, cardiovascular risk factors, and previous weight management attempts. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2[1]. Pregnant or breastfeeding individuals, and those with severe gastrointestinal disease, are also ineligible. The entire consultation takes under three minutes, and if approved, your medication is dispatched for next-day delivery to your Stockton-on-Tees address.

BMI Requirements and Comorbidity Assessment

BMI calculation is straightforward: weight in kilograms divided by height in metres squared. For Mounjaro Stockton-on-Tees eligibility, a BMI ≥30 kg/m² qualifies you without additional conditions, while a BMI of 27-29.9 kg/m² requires documented comorbidities such as prediabetes, established cardiovascular disease, or polycystic ovary syndrome (PCOS)[1]. Our clinical team reviews NHS records and self-reported health data to confirm suitability, ensuring safe and appropriate prescribing in line with NICE and MHRA guidance.

Mounjaro Stockton-on-Tees Dosing Schedule and Titration Protocol

Mounjaro Stockton-on-Tees treatment follows a structured dose-escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss. The starting dose is 2.5mg administered subcutaneously once weekly for four weeks, followed by an increase to 5mg for the next four weeks[1]. Depending on tolerability and response, your prescriber may escalate the dose every four weeks through 7.5mg, 10mg, 12.5mg, and up to a maximum maintenance dose of 15mg once weekly[2].

Each Mounjaro KwikPen contains four pre-filled doses, simplifying weekly administration. Injection sites include the abdomen, thigh, or upper arm, rotated weekly to reduce injection-site reactions. If you miss a dose and fewer than four days have passed, administer it as soon as possible; if more than four days have elapsed, skip the missed dose and resume your regular schedule[1]. Gradual titration is critical: rapid dose increases are associated with higher rates of nausea, vomiting, and diarrhoea, which can lead to treatment discontinuation.

Managing Side Effects During Dose Escalation

The most common side effects reported in SURPASS trials include nausea (17-22% of participants), diarrhoea (13-16%), and constipation (6-11%)[2]. These symptoms typically peak during the first few weeks after dose escalation and diminish with continued use. For Mounjaro Stockton-on-Tees patients experiencing persistent gastrointestinal discomfort, our clinical team may recommend remaining at your current dose for an additional four weeks before further escalation, or prescribing anti-emetic support such as domperidone or prochlorperazine. Staying well-hydrated, eating smaller frequent meals, and avoiding high-fat foods can also mitigate nausea.

Cost and Pricing of Mounjaro Stockton-on-Tees via Cured Pharmacy

Cured Pharmacy offers Mounjaro Stockton-on-Tees from £124.99 per four-dose box, with transparent upfront pricing displayed before you begin your clinical assessment. New patients receive £20 off their first order using the code Weightlossnew, reducing the initial cost to £124.99. Unlike many UK providers, we do not charge separate consultation fees, hidden administration costs, or delivery surcharges—what you see is what you pay.

Each box contains four single-dose pens, providing a full month of treatment. As you progress through dose escalation, the per-box price remains consistent, though higher-strength pens (10mg, 12.5mg, 15mg) may have different pricing. Our pricing model is designed to be competitive across the UK, ensuring residents of Stockton-on-Tees and the wider North East have access to genuine MHRA-licensed Mounjaro without the premium markups seen at high-street competitors. All orders include free next-day delivery in discreet, unmarked packaging.

How to Order Mounjaro Stockton-on-Tees Online with Home Delivery

Ordering Mounjaro Stockton-on-Tees through Cured Pharmacy is straightforward and fully compliant with UK pharmacy regulations. Begin by completing our free online medical consultation, which takes under three minutes and covers your weight history, current health conditions, medications, and lifestyle factors. Our UK-registered prescribers review your submission within hours, and if clinically appropriate, approve your prescription the same day.

Once approved, your Mounjaro is dispatched from our GPhC-registered pharmacy (registration number 9012511) via secure courier with tracking. Orders placed before 3pm Monday to Friday are eligible for next-day delivery to Stockton-on-Tees addresses, including TS16, TS17, TS18, TS19, TS20, and TS21 postcodes. All packaging is discreet with no external branding, and our clinical team is available by phone (+44 116 4646009) or email for any questions regarding administration, side effects, or dose adjustments[3].

Ongoing Support and Prescription Renewals

Mounjaro Stockton-on-Tees patients benefit from continuous clinical support throughout their weight loss journey. After your initial prescription, our team schedules follow-up assessments every 8-12 weeks to monitor progress, adjust dosing, and address any adverse effects. Prescription renewals are seamless: log into your Cured Pharmacy account, update your weight and health status, and your prescriber will review and approve your next supply. We also provide educational resources on nutrition, exercise, and behavioural strategies to maximise your results and support long-term weight maintenance[3].

Mounjaro Stockton-on-Tees vs Other Weight Loss Treatments Available Locally

When comparing Mounjaro Stockton-on-Tees options with alternatives such as Wegovy (semaglutide) or Saxenda (liraglutide), tirzepatide consistently demonstrates superior weight loss outcomes in head-to-head trials. The SURPASS-2 study showed tirzepatide 15mg resulted in 12.4% mean body weight reduction compared to 6.2% with semaglutide 1mg over 40 weeks[2]. While Wegovy remains an effective GLP-1 agonist, Mounjaro's dual-agonist mechanism offers enhanced efficacy for patients who have not achieved their goals with single-agonist therapies.

Saxenda, a daily injection of liraglutide, is another option but requires more frequent administration and typically yields lower average weight loss (5-7% in SCALE trials)[4]. For Stockton-on-Tees residents seeking the most potent pharmacological intervention, Mounjaro represents the current gold standard, though individual response varies. Our comparison table below outlines key differences in dosing frequency, mechanism, and starting price to help you make an informed choice in consultation with our prescribers.

Switching from Wegovy or Saxenda to Mounjaro in Stockton-on-Tees

If you are currently using Wegovy or Saxenda and considering a switch to Mounjaro Stockton-on-Tees, our clinical team can facilitate a safe transition. There is no mandatory washout period when switching from semaglutide or liraglutide to tirzepatide, though some prescribers prefer a one-week gap to minimise overlapping gastrointestinal side effects[1]. Your starting dose of Mounjaro will typically be 2.5mg regardless of your previous GLP-1 dose, with standard titration thereafter. Many patients report improved tolerability and accelerated weight loss after switching to tirzepatide, though individual results depend on adherence, diet, and metabolic factors[2].

Scientific References

1. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14094 [accessed 1 October 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., ... & Lingvay, I. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 1 October 2026]
3. General Pharmaceutical Council. (2024). Registered Pharmacies: Cured Pharmacy (Registration 9012511). Retrieved from https://www.pharmacyregulation.org/ [accessed 1 October 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 1 October 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 1 October 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 1 October 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 1 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.